Nvidia Goes Where No Stock Has Gone Before

Get caught up on what you missed last week! ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

AN OXFORD CLUB PUBLICATION

SPONSORED [Cancer Shocker] Cereal for Breakfast? There's a city in northern Europe where cancer rates are 4X LOWER than they are here... And researchers have traced it back to what they eat for breakfast. See what this popular cereal can do to cancer cells right here: 1 common breakfast cereal reprograms cancer cells? The cancer-fighting secret in this cereal used to be on every breakfast table in America... until it was abandoned for something more "convenient." See it here.

– NVIDIA'S FAVORITE BIOTECH –

Last week, Nvidia (Nasdaq: NVDA) broke the record for the largest market cap any company has ever achieved: $3.45 trillion! But Chief Income Strategist Marc Lichtenfeld has his eye on the company for a very different reason... A big investment it made in a little-known biotech company that's currently trading for only $10. Marc will be hosting an urgent broadcast this Thursday, June 27, at 2 p.m. ET to share more about Nvidia's favorite biotech... the company's highly anticipated upcoming announcement... and how he plans to play the whole situation. Don't miss this live event! Reserve your free spot by clicking here or on the button below. Claim Your Spot... for FREE

– SAFETY NET –

Marc is not a fan of a certain office supplies company... In fact, he has so little confidence in the stock that he recently recommended that his VIP subscribers take a bearish position in it. Is the company's 7% dividend yield as shaky as the stock itself? Safety Net Says...

– THE VALUE METER –

Globe Life (NYSE: GL) has been a steady performer in the insurance industry for decades, and it has the consistent cash generation that value investors crave. However, a disparaging report against the company recently caused its stock to fall off a cliff. Is this an attractive "buy low" opportunity? Here's what Director of Trading Anthony Summers thinks... Get Anthony's Take Here

– OVERHEARD –

"I've subscribed to several other experts' financial newsletters... none hold a candle to Marc." - Wealthy Retirement Reader Doug Have an experience that you'd like to share with the team at Wealthy Retirement? Click here to send us a message.

SPONSORED Nvidia's Best Kept Secret: The $10 Biotech Stock Igniting an AI Revolution A top Nvidia executive hinted at a biotech revolution, driven by AI, that could create the first trillion-dollar drug company. And there's one under-the-radar $10 stock right at the center. Join Marc Lichtenfeld, America's top stock catalyst expert, as he reveals details including the upcoming catalyst that could send this stock soaring! Secure your free spot here now!

– MORE FROM MARC –

EARN INCOME WHILE PLAYING THE HOTTEST SECTORS Marc says there's a gross misconception among some investors... He sets the record straight here.

– IN CASE YOU MISSED IT... –

"Many retirees who have plenty of money are reluctant to spend it... What might allow them to loosen the purse strings and live a fuller life?" "The Oxford Club has provided job opportunities, health services, better education and improved wellbeing for the people of [Nicaragua]. But we could not do it without the generous support of our Members... Donating only takes a minute, but it makes a dramatic, long-term difference in the lives of the wonderful people in this region." "One company stands tall in the fight against a silent killer... Don't miss out on the potential of this biotech gem."

Facebook LinkedIn

SPONSORED 82-Year-Old Cancer Patient Cured by AI Paul's chemo failed him six times. Then, one new company's AI-developed approach helped completely eliminate his blood cancer. Now Big Pharma is lining up to make giant deals with this company. Up to $6.8 billion with Merck, Sanofi and Bristol Myers Squibb alone. Watch this tech talk explaining why this company could be the #1 AI stock going forward.

You are receiving this email because you subscribed to Wealthy Retirement. Wealthy Retirement is published by The Oxford Club. Questions? Check out our FAQs. Trying to reach us? Contact us here. Please do not reply to this email as it goes to an unmonitored inbox. Privacy Policy | Whitelist Wealthy Retirement | Unsubscribe © 2024 The Oxford Club, LLC All Rights Reserved The Oxford Club | 105 West Monument Street | Baltimore, MD 21201 North America: 877.808.9795 | International: +1.443.353.4621 Oxfordclub.com

Nothing published by The Oxford Club should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed personalized investment advice. We allow the editors of our publications to recommend securities that they own themselves. However, our policy prohibits editors from exiting a personal trade while the recommendation to subscribers is open. In no circumstance may an editor sell a security before subscribers have a fair opportunity to exit. The length of time an editor must wait after subscribers have been advised to exit a play depends on the type of publication. All other employees and agents must wait 24 hours after publication before trading on a recommendation. Any investments recommended by The Oxford Club should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. The information found on this website may only be used pursuant to the membership or subscription agreement and any reproduction, copying or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of The Oxford Club, LLC, 105 West Monument Street, Baltimore, MD 21201.